Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes (Q47946026)

7 February 2018

review article

1 reference

title

Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes (English)

1 reference

7 February 2018

author name string

Jones RN

series ordinal

1

1 reference

7 February 2018

publication date

1 July 1998

1 reference

7 February 2018

Diagnostic Microbiology and Infectious Disease

published in

1 reference

7 February 2018

volume

31

1 reference

7 February 2018

issue

3

1 reference

7 February 2018

page(s)

461-466

1 reference

7 February 2018

The structure of β-lactamases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

A functional classification scheme for beta-lactamases and its correlation with molecular structure

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

Empiric therapy of bacterial infections in patients with severe neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

Beta-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

Prevalence of fluoroquinolone resistance in Europe. Study Group 'Bacterial Resistance' of the Paul-Ehrlich-Society for Chemotherapy e. V.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

beta-Lactamases in laboratory and clinical resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

The activity of cefpirome and ten other antibacterial agents against 2858 clinical isolates collected from 20 centres.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

The beta-lactamases of gram-negative bacteria and their possible physiological role.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

Penicillin-binding proteins and induction of AmpC beta-lactamase

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

The ability of beta-lactam antibiotics to select mutants with derepressed beta-lactamase synthesis from Citrobacter freundii

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900029-7

7 January 2021

10.1016/S0732-8893(98)00029-7

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018